Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Giant Creative/Strategy Names CEO and CFO

Partner Steven Gold Becomes Chief Executive May 20, 2015 08:00 AM Eastern Daylight Time SAN FRANCISCO–(BUSINESS WIRE)–Giant Creative/Strategy, LLC, the largest full-service independent healthcare communications agency on the West Coast, named Steven Gold as chief executive officer today and announced that Jeffrey Nemy has joined the company as chief financial officer. Gold, who is one […]

Read More »

Pfizer Board Member Jumps Ship to $217 Million Startup

Pfizer Inc. has announced Marc Tessier-Lavigne stepped down from the company’s board of directors Thursday. Tessier-Lavigne chose to leave the board at the same time that Denali, a biotechnology company that specializes in creating effective therapies to treat neurodegenerative diseases, was launched. Because Tessier-Lavigne is the co-founder of the new biotechnology company, he is leaving […]

Read More »

GW Pharma Relocates CEO and Taps Ex-Allergan Exec to Lead U.S. Biz in SoCal

GW Appoints Senior Industry Executive to President, North America and Relocates CEO to the U.S. U.S. Operations to be Located in Southern California LONDON, May 19, 2015 (GLOBE NEWSWIRE via COMTEX) — GW Pharmaceuticals plc (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary […]

Read More »

Publicis Touchpoint Solutions’ President & CEO, Michelle Keefe, Honored as a PM360 ELITE

Yardley, PA—May 19, 2015—Publicis Touchpoint Solutions, Inc —a leading provider of customized, omnichannel healthcare sales, service, and clinical teams—announced today that President and CEO Michelle Keefe has been named a PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) representing the most influential people in the healthcare industry today. PM360, a leading health-marketing industry […]

Read More »

Matt Giegerich Honored as an Inaugural ELITE Award Winner by PM360

PARSIPPANY, NJ–(Marketwired – May 19, 2015) – Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced that Matt Giegerich, chairman & CEO of the network, has been named a “Transformational Leader” by leading health-marketing industry trade magazine PM360 for its inaugural […]

Read More »

Ogilvy CommonHealth Worldwide’s Jill Lesiak Honored as HBA Rising Star

PARSIPPANY, NJ–(Marketwired – May 14, 2015) – Ogilvy CommonHealth Worldwide (, the health behavior change experts of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced Jill Lesiak, vice president, creative director at the network’s Parsippany-based agency, Ogilvy CommonHealth, was named an industry Rising Star by the Healthcare Businesswomen’s Association (HBA) […]

Read More »

Beacon Health Options Names Jay Curley as Executive Vice President, Corporate Affairs

BOSTON, May 13, 2015 /PRNewswire/ — Beacon Health Options (Beacon), the nation’s premier behavioral health management company, announced today that Jay Curley has joined the company as Executive Vice President, Corporate Affairs and Chief of Staff to Chief Executive Officer Tim Murphy. In his new role, Mr. Curley will develop and oversee Beacon’s corporate affairs […]

Read More »

Maureen Early Named Vice President, Commercial of Synthetic Biologics

— Appointment Reflects Company’s Expanded Clinical and Market Driven Focus —   For Immediate Release   Rockville, MD, May 7, 2015 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a microbiome-focused, clinical-stage company developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, announced Maureen Early joined the team in the newly created position of Vice […]

Read More »

Steven Shallcross Named Chief Financial Officer of Synthetic Biologics

— Executive Brings Significant Biotech Industry Leadership Experience to Team as Company Enters Next Phase of Development — For Immediate Release Rockville, MD, May 4, 2015 – Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of pathogen-specific therapeutics focused on protecting the microbiome, as well as treating other diseases, announced Steven A. Shallcross has been […]

Read More »

As Hampton Takes Over as Chairman at GlaxoSmithKline (GSK), CEO Witty Needs to Deliver or “Step Aside”

GlaxoSmithKline (GSK) is under scrutiny Tuesday, after more analysts have called for its longstanding chief executive, Sir Andrew Witty, to either step up his performance or resign within the next year, as the company prepares to receive its new chairman later this week. “Mr. Witty is running out of time,” said Stephen Bailey, a fund […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom